We are live on ! Find out more
CG

CFO4Life Group Portfolio holdings

AUM $743M
1-Year Est. Return 25.26%
This Fund
S&P 500
This Quarter Est. Return
+3.78%
1 Year Est. Return
+25.26%
3 Year Est. Return
+56.71%
5 Year Est. Return
+59.15%
10 Year Est. Return
AUM
$223M
AUM Growth
+$4.21M
Cap. Flow
-$2.27M
Cap. Flow %
-1.02%
Top 10 Hldgs %
53.12%
Holding
135
New
11
Increased
28
Reduced
64
Closed
11

Sector Composition

Rank Sector Weight
1 Miscellaneous 34.29%
2 Industrials 24.17%
3 Technology 9.42%
4 Financials 8.91%
5 Consumer Staples 7.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EFV icon
126
iShares MSCI EAFE Value ETF
EFV
$31.5B
-5,526
Closed -$266K
LEA icon
127
Lear
LEA
$6.08B
-1,489
Closed -$207K
LULU icon
128
lululemon athletica
LULU
$10.6B
-3,000
Closed -$541K
MRCC
129
DELISTED
Monroe Capital Corp
MRCC
-14,353
Closed -$166K
NFLX icon
130
Netflix
NFLX
$318B
-6,060
Closed -$223K
SPDW icon
131
State Street SPDR Portfolio Developed World ex-US ETF
SPDW
$41.3B
-7,395
Closed -$219K
SSNC icon
132
SS&C Technologies
SSNC
$18.9B
-6,206
Closed -$358K
ZION icon
133
Zions Bancorporation
ZION
$9.56B
-13,407
Closed -$616K
BT
134
DELISTED
BT Group plc (ADR)
BT
-18,037
Closed -$230K
APU
135
DELISTED
AmeriGas Partners, L.P.
APU
-9,230
Closed -$322K

Similar funds

CFO4Life Group's Q3 2019 Portfolio in Review

As of Q3 2019, CFO4Life Group held 135 positions worth $223M, up 1.9% from $219M the previous quarter. Its ten largest holdings account for 53% of the portfolio.

CFO4Life Group's Q3 2019 filing shows 11 new, 28 increased, 64 reduced and 11 closed positions. Its largest new stake was Leidos: 6,499 shares worth $558K. The largest sale was Pfizer, an estimated $669K.

By sector, the portfolio is most concentrated in Miscellaneous at 34% of assets, up from 33% a quarter earlier, followed by Industrials and Technology.

  • CFO4Life Group's largest Q3 2019 buy was Leidos: 6,499 shares worth $558K.
  • CFO4Life Group added most to iShares MSCI USA Min Vol Factor ETF in Q3 2019, an estimated $640K increase.
  • CFO4Life Group's biggest Q3 2019 reduction was Pfizer, cutting an estimated $669K.
  • CFO4Life Group fully exited Zions Bancorporation in Q3 2019, selling an estimated $616K.
  • CFO4Life Group's ten largest holdings make up 53% of its $223M portfolio in Q3 2019.
  • CFO4Life Group opened 11 new positions and closed 11 in Q3 2019.
  • CFO4Life Group's portfolio value rose 1.9% quarter-over-quarter to $223M.

Based on CFO4Life Group's 13F filing for Q3 2019, filed 1 Nov 2019.